Co-Infection of Parvovirus B19, CMV and BK Virus after Renal Transplantation
- 1 Department of Nephrology and Endocrinology, Children Hospital 2, Ho Chi Minh City, Vietnam
Abstract
Background: Parvovirus B19 is the agent causing a regenerative anemia in organ transplant recipients, due to their immunodepressive status. The diagnosis is usually confirmed by the presence of virus in the blood and bone marrow via the PCR technique. There is a potential co-infection with other opportunistic viruses in the transplanted patients. However, this population is not routinely screened for Parvovirus B19 infection. Case Report: A 14-year-old male patient who received living-donor kidney transplantation developed a severely progressive and aregenerative anemia four weeks later. PCR of Parvovirus B19 was positive from bone marrow aspiration. There were concomittant CMV and BK virus co-infection. The treatment included a reduction of immunosuppressants, intravenous gamma globulin. Valganciclovir has been prescribed for three months that could negativate the CMV blood load. At the end, there was an eradication of parvovirus in the bone marrow. Conclusion: This first reported case in Viet Nam which informed that infection with Parvovirus B19 should be investigated in the transplanted population when a regenerative anemia is present. Otherwise, a screening strategy for Parvovirus B19 should also be considered.
- Waldman, M. and Kopp, J.B. (2007) Parvovirus B19 and the Kidney. Clinical Journal of the American Society of Nephrology, 2, 47-56. https://doi.org/10.2215/CJN.01060307
- Jordan, J.A. (1996) Identification of Human Parvovirus B19 Infection in Idiopathic Nonimmune Hydrops Fetalis. American Journal of Obstetrics and Gynecology, 174, 37-42. https://doi.org/10.1016/S0002-9378(96)70370-8
- Zilinska, Z., Chrastina, M., Breza, J. and Drakulova, M. (1989) Parvovirus B19 Infection—The Cause of Severe Anaemia after Renal Transplantation. Microbial Pathogenesis, 7, 319-327.
- Zolnourian, Z.R., Curran, M.D., Rima, B.K., Coyle, P.V., O’Neill, H.J. and Middleton, D. (2000) Parvovirus B19 in Kidney Transplant Patients. Transplantation, 69, 2198-2202. https://doi.org/10.1097/00007890-200005270-00043
- Kasiske, B.L., Zeier, M.G., Chapman, J.R., Craig, J.C., Ekberg, H., et al. (2010) KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients: A Summary. Kidney International, 77, 299-311. https://doi.org/10.1038/ki.2009.377
- Cavallo, R., Merlino, C., Re, D., Bollero, C., Bergallo, M., Lembo, D., Musso, T., Leonardi, G., Segoloni, G.P. and Ponzi, A.N. (2003) B19 Virus Infection in Renal Transplant Recipients. Journal of Clinical Virology, 26, 361-368. https://doi.org/10.1016/S1386-6532(02)00104-X
- Eid, A.J., Brown, R.A., Patel, R. and Razonable, R.R. (2006) Parvovirus B19 Infection after Transplantation: A Review of 98 Cases. Clinical Infectious Diseases, 43, 40-48. https://doi.org/10.1086/504812
- Moudgil, A., Shidban, H., Nast, C.C., Bagga, A., Aswad, S., Graham, S.L., Mendez, R. and Jordan, S.C. (1997) Parvovirus B19 Infection-Related Complication in Renal Transplant Recipients: Treatment with Intravenous Immunoglobulin. Transplantation, 64, 1847-1850. https://doi.org/10.1097/00007890-199712270-00037
- Choi, S.H., Chang, S.P., Won, J.C., Lee, J.S., Chi, H.S., Yang, W.S. and Park, S.K. (2002) A Case of Persistent Anemia in a Renal Transplant Recipient: Association with Parvovirus B19 Infection. Scandinavian Journal of Infectious Diseases, 34, 71-75. https://doi.org/10.1080/003655402753395247
- Liefeldt, L., Buhl, M., Schweickert, B., Engelmann, E., Sezer, O., Laschinski, P., Preuschof, L. and Neumayer, H.-H. (2002) Eradication of Parvovirus B19 Infection after Renal Transplantation Requires Reduction of Immunosuppression and High-Dose Immunoglobin Therapy. Nephrology Dialysis Transplantation, 17, 1840-1842. https://doi.org/10.1093/ndt/17.10.1840